Jove
Visualize
Contact Us

Related Experiment Videos

Thalassaemia: clinical management.

N Olivieri1

  • 1Division of Hematology/Oncology, Hospital for Sick Children, Toronto, Ontario, Canada.

Bailliere'S Clinical Haematology
|June 29, 2000
PubMed
Summary

Recent advances in thalassaemia major management have improved patient outcomes in developed nations. However, access to effective treatments like transfusions and iron chelation remains a challenge in emerging countries, highlighting the need for broader implementation and experimental therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of fractures among the Thalassemia syndromes in North America.

Bone·2005
Same author

Response of CD-1 mice to the chemical defence of a common arthropod (Ommatoiulus sabulosus).

Physiology & behavior·2001
Same author

Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial.

Transfusion·2001
Same author

A survey of the primary structure and the interspecies conservation of I-band titin's elastic elements in vertebrates.

Journal of structural biology·1998
Same author

Organelle membrane fusion: a novel function for the syntaxin homolog Ufe1p in ER membrane fusion.

Cell·1998
Same author

Stroke prevention trial in sickle cell anemia.

Controlled clinical trials·1998
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Hematology
  • Genetics
  • Pharmacology

Background:

  • Thalassaemia major management has significantly advanced, improving patient prognosis.
  • Developed countries commonly achieve survival into the fourth decade with regular transfusions and iron-chelating therapy.
  • Complications associated with thalassaemia major are now infrequently observed in well-resourced settings.

Purpose of the Study:

  • To review recent therapeutic advances in thalassaemia major.
  • To discuss the progress in experimental treatment approaches for thalassaemia.
  • To highlight the disparity in treatment access between developed and emerging countries.

Main Methods:

  • Literature review of recent advancements in thalassaemia major treatment.
  • Analysis of current transfusion and iron-chelating therapy protocols.
  • Overview of ongoing experimental therapeutic strategies.

Main Results:

  • Improved survival rates and reduced complications in countries with established treatment programs.
  • Significant disparities in access to advanced therapies in emerging economies.
  • Promising progress in novel and experimental treatment modalities.

Conclusions:

  • Current management strategies have transformed thalassaemia major outcomes in affluent regions.
  • Urgent need for wider implementation of effective treatments in resource-limited settings.
  • Continued research into experimental therapies is crucial for global thalassaemia management.

Related Experiment Videos